The undiscovered country: The future of integrating genomic information into the EHR

Genetics in Medicine

Volumn 15, Issue 10, 2013, Pages 842-845

  Kannry, Joseph ^a   Williams, Marc S ^a  

^a MOUNT SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTATION; ARTICLE; ECHOCARDIOGRAPHY; EDUCATION; ELECTRONIC MEDICAL RECORD; GENETIC ANALYSIS; GENETIC SCREENING; GENOMICS; HEALTH CARE; HUMAN; INTERPERSONAL COMMUNICATION; TAXONOMY;

ELECTRONIC HEALTH RECORDS; GENOMICS; HUMANS; PHARMACOGENETICS; TRANSLATIONAL MEDICAL RESEARCH;

EID: 84885160852     PISSN: 10983600     EISSN: 15300366     Source Type: Journal    
DOI: 10.1038/gim.2013.130     Document Type: Article

References (51)

1. Gottesman O, Kuivaniemi H, Tromp G, et al. The Electronic Medical Records and Genomics (eMERGE) Network: past, present and future. Genet Med 2013;15:761-771.
2. Powell K P, Christianson CA, Cogswell WA, et al. Educational needs of primary care physicians regarding direct-to-consumer genetic testing. J Genet Couns 2012;21:469-478.
3. Hartzler A, McCarty CA, Rasmussen LV, et al. Stakeholder engagement: a key component of integrating genomic information into electronic health records. Genet Med 2013;15:792-801.
4. Hazin R, Brothers KB, Malin BA, et al. Ethical, legal and social implications of incorporating genomic information into electronic health records. Genet Med 2013;15:810-816
5. Kannry J, Beuria P, Wang E, Nissim J. Personal health records: meaningful use, but for whom? Mt Sinai J Med 2012;79:593-602
6. Matsuda I, Niikawa N, Sato K, et al.; Japan Society of Human genetics, Council Committee of Ethics. Guidelines for genetic testing. The Japan Society of Human Genetics, Council Committee of Ethics. J Hum Genet 2001;46:163-165
7. Goldman JS, Hahn SE, Catania JW, et al.; American College of Medical Genetics and the National Society of Genetic Counselors. Genetic counseling and testing for Alzheimer disease: joint practice guidelines of the American College of Medical Genetics and the National Society of Genetic Counselors. Genet Med 2011;13:597-605
8. Craufurd D, Tyler A. Predictive testing for Huntington's disease: protocol of the UK Huntington's Prediction Consortium. J Med Genet 1992;29:915-918
9. Kaufman DJ, Bollinger JM, Dvoskin RL, Scott JA. Risky business: risk perception and the use of medical services among customers of DTC personal genetic testing. J Genet Couns 2012;21:413-422
10. Vayena E, Gourna E, Streuli J, Hafen E, Prainsack B. Experiences of early users of direct-to-consumer genomics in Switzerland: an exploratory study. Public Health Genomics 2012;15:352-362
11. Delbanco T, Walker J, Bell SK, et al. Inviting patients to read their doctors' notes: a quasi-experimental study and a look ahead. Ann Intern Med 2012; 157:461-470
12. McGuire AL, Cho MK, McGuire SE, Caulfield T Medicine. The future of personal genomics. Science 2007;317:1687
13. Starren J, Williams MS, Bottinger EP. Crossing the omic chasm: a time for omic ancillary systems. JAMA 2013;309:1237-1238
14. Nickola TJ, Green JS, Harralson AF, O'Brien TJ. The current and future state of pharmacogenomics medical education in the USA. Pharmacogenomics 2012;13:1419-1425
15. Bonter K, Desjardins C, Currier N, Pun J, Ashbury FD. Personalised medicine in Canada: a survey of adoption and practice in oncology, cardiology and family medicine. BMJ Open 2011;1:e000110
16. Babyatsky M, Giovanni M, Murray M. Clinical Genomics: Practical Applications in Adult Patient Care. McGraw Hill, 2013
17. Liaw ST. Genetics and genomics in general practice. Aust Fam Physician 2010;39:689-691
18. Gullapalli RR, Desai KV, Santana-Santos L, Kant JA, Becich MJ. Next generation sequencing in clinical medicine: Challenges and lessons for pathology and biomedical informatics. J Pathol Inform 2012;3:40
19. Brewer NT, Tzeng JP, Lillie SE, Edwards AS, Peppercorn JM, Rimer BK Health literacy and cancer risk perception: implications for genomic risk communication. Med Decis Making 2009;29:157-166
20. Manolio TA, Chisholm RL, Ozenberger B, et al. Implementing genomic medicine in the clinic: the future is here. Genet Med 2013;15:258-267
21. Hassell L, Aldinger W, Moody C, et al. Electronic capture and communication of synoptic cancer data elements from pathology reports: results of the Reporting Pathology Protocols 2 (RPP2) project. J Registry Manag Winter 2009;36(4):117-124
22. Baskovich BW, Allan RW. Web-based synoptic reporting for cancer checklists. J Pathol Inform 2011;2:16.
23. Dolin RH, Alschuler L, Boyer S, et al. HL7 Clinical Document Architecture, Release 2. J Am Med Inform Assoc 2006;13:30-39
24. Groups HCGaSDW. CDA Implementation Guide: Genetic Testing Report (GTR), 2013. http://www.hl7.org/documentcenter/public-temp-20DA1AE7-1C23-BA17- 0CCEBE0F4D95D6A8/wg/clingenomics/presentations/CDA%20IG%20 for%20Genetic%20Testing%20Report%20-%20May%202013%20-%20 Shabo.pdf. Accessed 16 July 2013
25. Chute CG, Ullman-Cullere M, Wood G, Lin SM, He M, Pathak J. Some experiences and opportunities for big data in translational research. Genet Med 2013;15:802-809
26. Overby CL, Kohane I, Kannry JL, et al. Opportunities for genomic clinical decision support interventions. Genet Med 2013;15:817-823
27. Marsolo K, Spooner SA. Clinical genomics in the world of the electronic health record. Genet Med 2013;15:786-791
28. PharmaGKb CPICC. CPIC Gene-Drug Pairs. http://www.pharmgkb.org/page/ cpicGeneDrugPairs. Accessed 2 July 2013
29. US Food and Drug Administration. Black Box Warning for Plavix, 2010. http://www.accessdata.fda.gov/drugsatfda-docs/label/2010/020839s042lbl.pdf Accessed 11 July 2013
30. Goswami S, Cheng-Lai A, Nawarskas J. Clopidogrel and genetic testing: is it necessary for everyone? Cardiol Rev 2012;20:96-100.
31. Kim KM, Murray MD, Tu W, et al. Pharmacogenetics and healthcare outcomes in patients with chronic heart failure. Eur J Clin Pharmacol 2012;68:1483-1491
32. Mette L, Mitropoulos K, Vozikis A, Patrinos GP Pharmacogenomics and public health: implementing 'populationalized' medicine. Pharmacogenomics 2012;13:803-813
33. BartlettMJ, Green DW, Shephard EA. Pharmacogenetic testing in the UK clinical setting. Lancet2013;381:1903.
34. Turner RM. From the lab to the prescription pad: genetics, CYP450 analysis, and medication response. J Child Adolesc Psychiatr Nurs 2013;26:119-123
35. US Food and Drug Administration. Ziagen (abacavir) Safety Warning, 2008. http://www.fda.gov/Safety/MedWatch/SafetyInformation/ SafetyAlertsforHumanMedicalProducts/ucm079913.htm. Accessed 11 July 2013
36. Peterson JF, Bowton E, Field JR, et al. Electronic health record design and mplementation for pharmacogenomics: a local perspective. Genet Med 2013;15:833-841
37. Kho AN, Rasmussen LV, Connolly JJ, et al. Practical challenges integrating genomic data into the electronic health record. Genet Med 2013;1 5 772-778
38. Tarczy-Hornoch P, Amendola L, Aronson SJ, et al. A survey of informatics approaches to whole-exome and whole-genome clinical reporting in the electronic health record. Genet Med 2013;15:824-832
39. Wright A, Sittig DF A framework and model for evaluating clinical decision support architectures. J Biomed Inform 2008;41:982-990
40. Kannry J. Computerized physician order entry and patient safety: Panacea or Pandora's Box? In: Ong KR (ed). Medical Informatics: An Executive Primer HIMSS: Chicago, IL, 2007:xviii, 316
41. Evans JP, Khoury MJ. The arrival of genomic medicine to the clinic is only the beginning of the journey. Genet Med 2013;15:268-269
42. Ury A. Storing and interpreting genomic information in widely deployed electronic health record systems. Genet Med 2013;15:779-785
43. Wright A, Sittig DF. A four-phase model of the evolution of clinical decision support architectures. Int J Med Inform 2008;77:641-649
44. Kawamoto K, Del Fiol G, Orton C, Lobach DF. System-agnostic clinical decision support services: benefits and challenges for scalable decision support. Open Med Inform J2010;4:245-254.
45. Hongsermeier T, Maviglia S, Tsurikova L, et al. A legal framework to enable sharing of Clinical Decision Support knowledge and services across institutional boundaries. AMIAAnnu Symp Proc2011;2011:925-933
46. Bates DW, Kuperman GJ, Wang S, et al. Ten commandments for effective clinical decision support: making the practice of evidence-based medicine a reality. J Am Med Inform Assoc 2003;10:523-530
47. McGuire AL, Fisher R, Cusenza P, et al. Confidentiality, privacy, and security of genetic and genomic test information in electronic health records: points to consider. Genet Med 2008;10:495-99
48. Allain DC, Friedman S, Senter L. Consumer awareness and attitudes about nsurance discrimination post enactment of the Genetic Information Nondiscrimination Act. Fam Cancer2012;11:637-644
49. Clifton JM, VanBeuge SS, Mladenka C, Wosnik KK. The Genetic Information Nondiscrimination Act 2008: What clinicians should understand. J Am Acad Nurse Pract2010;22(5):246-249
50. Feldman EA. The Genetic Information Nondiscrimination Act (GINA): public policy and medical practice in the age of personalized medicine. J Gen Intern Med 2012;27:743-746
51. Ginsburg GS, Willard HF. Genomic and personalized medicine: foundations and applications. Transl Res 2009;154:277-287